期刊文献+

Ca^(2+)阻滞剂非洛地平对高脂饮食SD大鼠颈动脉球囊损伤后内膜增生的影响 被引量:1

Effect of Ca^(2+) blocker on neointimal hyperplasia of balloon injured carotid artery in SD rats
下载PDF
导出
摘要 目的观察Ca2+阻滞剂非洛地平对高脂饮食SD大鼠颈动脉球囊损伤后动脉内膜增生的影响。方法2F球囊导管造成大鼠颈动脉内膜剥脱后,将27只大鼠随机分为3组,标准饲料组,高脂饲料组、高脂饲料+非洛地平组(5mg.kg-1.day-1)。给药3个月测定血压后,腹主动脉取血,并行腹主动脉插管灌注固定颈总动脉,HE(苏木素/伊红)染色,用图象分析仪观察颈总动脉血管腔面积(L)、血管壁(中膜)面积(W),并计算其比值(W/L)。分光光度计分别测定血浆谷胱甘肽水平及谷胱甘肽过氧化酶、谷胱甘肽还原酶活性。结果高脂饲料组SD大鼠血浆甘油三酯(triglyceride,TG)、胆固醇(cholesterol,TC)、LDL水平较标准饲料组明显增高(P<0.05),与高脂饲料组比较,非洛地平组血浆脂质代谢产物MDA水平显著降低(P<0.05),GXH、高密度脂蛋白胆固醇(high densitylipoprotein-cholesterol,HDL-C)水平明显升高(P<0.05),皿浆谷胱甘肽还原酶及其过氧化酶活性明显增强(P<0.05);损伤颈动脉高脂饲料组明显增厚,局部并有斑块形成。非洛地平组W/L明显著小于高脂饲料组(P<0.05)。结论(1)Ca阻滞剂可降低高脂饮食SD大鼠颈动脉球囊损伤后内膜增生;(2)Ca阻滞剂可增加SD大鼠血浆谷胱甘肽,谷胱甘肽过氧化酶、谷胱甘肽还原酶活性,降低血脂代谢产物MDA水平。(3)高脂条件氧化还原产物失衡可能是血管内膜损伤后增生的重要因素。 OBJECTIVE To observe the effect of Ca^2+ blocker(felodipine) on neointimal hyperplasia of the balloon injured carotid artery in SD rats. METHODS A 2F Foley's tube was used to develop a rat carotid artery neointimal hyperplasia modelby endothelial denudation in 27 SD rats. Then, the 27 SD rats were randomly divided into three groups, standard chow( Group NC, n = 9 ), high-fat diet( Group HF, n = 9 )or Felodipine (100 mg · kg^-1·day^-1) + high- fat diet( Group CB ,n = 9). After the three month, blood pressure was measured, and the abdominal artery was cannulated for fixation of the carotid artery. The area of lumina, the thickness of wall and the ratio of wall to Lanen of the carotid artery were obtained using an image analysis system. Serum cysteinylglycine levels as well as serum glutathione peroxidase and reductase activity were determined by spectrum meter. RESULTS The serum levels of TG,TCand LDL were significantly increased in Group HF compared with those in Group NC ( P 〈 0. 05 ). In Group CB ,the serum levels of cysteinylglycine and HDL-C were significantly increased while serum MDA( the metabolic product of lipoids)was significantly decreased,and the serum glutathione peroxidase and reductase activity significantly enhanced when compared with Group HF( P 〈 0. 05 ). on the injured sides of the carotid artery, significant thickening and local plaque formation were observed in the HF Group, whose W/L ratio of the carotid artery was significantly higher than Group CH ( P 〈 0. 05 ) ; CONCLUSION ( 1 ) Ca^2+ -blocker can ameliorate the neointimal hyperplasia of the balloon injured carotid artery in SD fed with high-fatdiet. (2) Ca^2+-blocker can increase serum cysteinylglycine levels and enhance the activity of glutathione peroxidase and reductase, while reduce serum MDA levels. (3) The disequilibrium of oxidoreduction products under the condition of hyperlipid may be an important reason of neointimal hyperplasia after vessel injury.
出处 《海峡药学》 2007年第11期24-27,共4页 Strait Pharmaceutical Journal
关键词 Ca^2+阻滞剂 球囊血管成形术 颈动脉 动脉硬化 Ca^2+ blocke Balloon angioplasty Carotid artery Arteriosclerosis
  • 相关文献

参考文献12

  • 1Cherubim A ,Vigna GB ,Zuliani G,et al. Role of antioxidants in atherosclerosis: epidemiological and clinical update [ J ]. Curr pHarm Des. 2005:11 (16) :2017-32.
  • 2Tribble DL, Baicellos, MH, eta Ionizing radiation acceterates arotic lesion formation in fat-fed mice via SOD-inhibitable procosses [ J ] Arterioscler Thromb Vase Biot,1999,19(6) :1387-1392.
  • 3Rodriguez JA, Nespereira B, Perez-Ilzarbe N et al. Vitamins C and E prevent endothelial vEGF and Ⅶ GFR-2 overexpression induced by porcine hypercholesterolemic LDL. Cardiovasc Res. 2005 Feb 15:65 (3) :665-73.
  • 4Alexander BW. Hypertension and the Pathogenesis of Atheroselerosis : Oxidative Stress and the Mediation of Arterial Inflammatory Response:A New Perspective. Hypertension 1995:25 (2) : 155-61.
  • 5Yokoyam M, Kawashim S. Role of the vascular NADH/NADpH oxidase system in the atherosclerosis [ J ]. Annual acad Sci, 2000. 902241-902247.
  • 6Hua Cai, David G, Harri son. Endothelial dysfunction in cardiovascular disease [ J ]. Cite Res,2000.10 : 840-843.
  • 7Bouloumie A, Marumo T, Marumo T, et al. Leptin induces oxidatives stress in human endothelial cells[J]. Faseb J ,1999,13:1231.1238.
  • 8Yamaguchi Y, Kunito M, Haginaka J. Role of endothelial dysfunction in atheroselerosis[ J ]. Circulation,2004,109 (23 Suppl 1 ) :III 27-32.
  • 9Rai J L, DeMaster EG, Jaimes EA, et al. Cigarette smoke induced endothelium dysfunction : role of superoxide anion [ J ]. Hypertension, 2001,19:891. 897.
  • 10Mnnu KM, Zilmer M, Fellstrom B. Endothelium-dependent vasodilation and oxidative stress in chronic failure:Impact on cardiovascular disease[ J ]. Kidney Int Suppl,2003,84:50-53.

同被引文献11

  • 1周磊,温国明,郭民法,黄霞,何万红,宁景春,张春蓉.非洛地平对高血压患者动脉粥样硬化和血管内皮功能的影响[J].实用临床医药杂志,2006,10(3):41-43. 被引量:5
  • 2Kanters E, Gijbels MJ, van der Made I, et al. Hematopoietic NF-kappa B1 deficiency results in small atherosclerotic lesions with an inflammatory phenotype. Blood, 2004, 103 (3) : 934- 940.
  • 3Monaco C,Andreakos E, Kiriakidis S, et al. Canonical pathway of nuclear factor kappa B activation selectively regulates proinflammatory and prothrombotic responses in human atherosclerosis. Proc Natl Acad Sci USA,2004;101(15):5634- 5639.
  • 4Simon A, Gariepy J, Moyse D, et al. Differential effects of nifedipine and CO-amilozide on the progression ofearly carotid wall changes. Circulation,2001 ,103(24) :2949-2954.
  • 5Pitt B, Bymgton RF, Furberg CD, et al. Effect of amlodipine on the progression of atheroselerosis and the occurrence of clinical events. PREVENT Investigators. Circulation,2000;102 (13) : 1503-1510.
  • 6Nonaka M, Chen XH, Pierce JE, et al. Prolonged activation of NF-kappaB following traumatic brain injury in rats. Neurotrauma, 1999 , 16 (11) : 1023-1034.
  • 7Ross R. Atherosclerosis-an inflammatory disease. N Eng J Med,1999 ,340(2) : 115-126.
  • 8Poston RN, Haskard DO, Coueher JR, et al. Expression of intercellular adhesion molecule-1 in atherosclerotic plaques. Am J Pathol,1992;140(3) :665-673.
  • 9Foulds S, Galustian C, Mansfield AO, et al. Transcription factor NF kappa B expression and postsurgical organ dysfunction. Ann Surg, 2001 ; 233 (1) : 770-781.
  • 10Yamagishi S, InagakiY, Nakamura K, et al. Azelnidipine, a newly developed long-acting calcium antagonist inhibits tumor necrosis factor-a-induced interleukin-8 expression in endothelial cells through its antioxidative properties. Cardlovasc Pharmacol, 2004 , 43 (7): 724-730.

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部